About Qankorey
SINCE → 2014
Founded in 2014, Hunan Qankorey is a biotechnology enterprise focusing on the key technology research of Alzheimer's Disease (AD), which is a difficult medical problem in the world. Over the years, Qankorey has cooperated with Australian Florey Research Institute and AIBL organization for scientific research, and cooperated with a number of well-known domestic tertiary hospitals and institutions to jointly carry out the transformation of scientific and technological achievements in the prevention and treatment of diseases of the elderly and the application of the market, and to create a platform for international exchanges of scientific research combined with clinical research.
The company has always adhered to independent innovation, invited the international top brain neuroscientist, the creator of the theory of natural phagocytosis, Prof. Baijun Gu, as the chief scientist, and set up an international high-precision research team. The company is deeply engaged in the field of Alzheimer's disease, and has a R&D layout in the whole industry chain of screening, diagnosis, intervention and treatment of Alzheimer's disease based on the Aβ monoclonal antibody exclusively researched and developed by the company, and has obtained more than 160 intellectual property rights, of which there are more than 10 international patents under PCT.
Looking to the future, Qankorey will continue to fulfill its mission of providing comprehensive Alzheimer's disease solutions for patients and families around the world through scientific and technological innovation, focusing on core technologies, integrating global resources, and continuously developing and innovating to serve public health!
